Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis image

Novartis eye drug succeeds in Phase III trial

August 16, 2012
Sales and Marketing FDA, Novartis, Ocriplasmin, Roche, VMA

Novartis has posted positive results for its investigational eye drug ocriplasmin. The Phase III study found that ocriplasmin significantly resolved …

News
Patientslike me image

MSD joins forces with PatientsLikeMe for psoriasis

August 14, 2012
Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis

MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …

News
novartis_window

New Avastin data could be bad news for Lucentis

August 14, 2012
Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …

News

Novartis pledges to maintain R&D presence in Horsham

August 14, 2012
Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts

Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …

News

Novartis and Pennsylvania team up on cancer research

August 6, 2012
Research and Development Cancer, Novartis, University of Pennsylvania, chimeric antigen receptor

Novartis and the University of Pennsylvania have joined forces to investigate a method of treating cancer which encourages patients’ immune …

News
david-meek

Novartis’ David Meek moves to Endocyte

July 30, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …

Appointment

Ireland agrees deal on medicines

June 28, 2012
Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing

Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …

News

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

News
Novartis image

Pharma companies share $400m US biosecurity contract

June 26, 2012
Manufacturing and Production Emergent BioSolutions, GSK, Novartis, manufacturing

GlaxoSmithKline, Novartis and Emergent BioSolutions will share a $400 million contract from the US government to provide vaccine manufacturing capacity …

News

Afinitor recommended in Europe for breast cancer

June 22, 2012
Sales and Marketing Afinitor, CHMP, Cancer, Novartis, breast

A European committee is recommending Novartis’ Afinitor to treat women with a certain type of breast cancer. The CHMP says …

News

Packaging errors spark fourth oral contraceptive recall

June 12, 2012
Manufacturing and Production Introvale, Novartis, Sandoz, manufacturing, recall

There has been yet another case of an oral contraceptive being recalled because packaging errors could lead to unwanted pregnancy, …

News

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012
Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …

News
Gilenya image

Gilenya to stay on US market – but with new safety warnings

May 15, 2012
Sales and Marketing EMA, FDA, Novartis, PML, gilenya

The FDA says that Novartis’ multiple sclerosis pill Gilenya should stay on the market, but has added new safety warnings …

News

Former Novartis man becomes GSK’s new medical director

May 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …

Appointment
Novartis image

Novartis to acquire Fougera for $1.5 billion

May 3, 2012
Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya

Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash.  Novartis’ generic unit Sandoz is conducting the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025